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Gap junctions, formed by the connexin (Cx) protein family, are intercellular channels that permit the cytoplasmic exchange of ions and
small metabolites between neighboring cells, a process called gap junction intercellular communication (GJIC). These channels possess
unique properties, including distinctive permeabilities for various signaling molecules, which depend on the connexin member(s) that form
them. Importantly, GJIC must be properly controlled as its misregulation might contribute to diseases. Morphological and functional studies
have revealed ‘gap junction-like’ structures and cell-to-cell communication involving cells of the immune system. The connexins involved in
such contacts have been partially identified in recent years. This review focuses on the potential physiological roles of gap junctions in the
development and recruitment of leukocytes as well as in the regulation of the immune response. Furthermore, the importance of GJIC in
immuno-inflammatory pathologies is illustrated in atherosclerosis.
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Inflammation has evolved as a mechanism to defend the
body against invading microorganisms and to respond to
injuries. In both physiological and inflammatory leukocyte
migration, immune cells have to breach the vascular barrier,
a process referred to as diapedesis, extravasation or endo-
thelial transmigration. The endothelium changes when there
is an injury in the underlying tissue, such that a normally
non-permissive surface becomes permissive for the adhe-
sion of circulating leukocytes thus supporting the recruit-
ment of inflammatory cells from the blood stream. A multi-
step adhesion cascade has been proposed for leukocyte
recruitment consisting of four steps [1,2]. In the first step,
leukocytes tether then roll on the endothelial cells (ECs).
This is followed by a triggering step, via chemokines and
their receptors, that leads to the rapid activation of leukocyte
integrins, and then a third step at which point the leukocyte0008-6363/$ - see front matter D 2004 European Society of Cardiology. Publishe
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(B.R. Kwak).adheres tightly onto the endothelial surface. Finally, diape-
desis occurs and the leukocyte crawls across ECs. Recent
reviews concerning endothelial junctions and leukocyte
transmigration have highlighted how molecules of the
adherens and tight junctions regulate leukocyte extravasa-
tion [3,4]. Although gap junctions were previously thought
not to play a role in leukocyte transmigration, recent data
challenges this view.
Gap junctions, formed by the connexin (Cx) protein
family, connect adjacent cells together thus providing a
direct means of intercellular communication [5]. Six con-
nexins assemble in the plasma membrane to make a con-
nexon or hemichannel. Two hemichannels from neighboring
cells join to form an intercellular channel that clusters with
other intercellular channels to build a gap junction. There
are presently over 20 connexins, each of which can create
functional channels with certain isoforms [6,7]. Gap junc-
tion channels formed by different connexins have unique
properties including distinctive permeabilities for various
dyes and signaling molecules [7,8]. Increasing data suggest
that connexons expressed on the plasma membrane of a
variety of cells might be more than just precursors for the
formation of gap junction channels [9,10]. In fact, thed by Elsevier B.V. All rights reserved.
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various connexins have been observed. Furthermore, some
hemichannels have been shown to be permeable to a
number of substances, including important signaling mole-
cules [10–13]. Much evidence, obtained from various cell
systems, has shown the regulation of connexin expression
and gap junctional intercellular communication (GJIC) by
pro-inflammatory mediators, thus uncovering the impor-
tance of gap junctions in the modulation of the inflamma-
tory response [14–18]. In this part of the spotlight issue, we
focus on gap junctions in leukocytes and the immune
response, specifically on their importance in the process of
leukocyte maturation and recruitment. In particular, the
development of atherosclerosis is presented to illustrate
the role played by GJIC in immuno-inflammatory diseases.2. Evidence for gap junction communication in
leukocytes
Leukocytes are principal players in the immune system
that undergo a developing process in order to deal with
infections and injuries inflicted to the body. To fight off
unwanted aggressors, leukocytes must leave their site of
production, circulate in the blood, and get recruited to the
initial spot of injury. This process requires coordinated
communications between leukocytes and other cells. The
role of GJIC during these different steps is slowly emerging.
2.1. Leukocyte formation
All blood cells originate from a common hematopoietic
stem cell. In the adult, the stem cells are found mainly in the
bone marrow and thymus, where they can either divide to
produce more pluripotent stem cells or differentiate to
various committed progenitor cells, each able to generate
only one or a few types of blood cells. This process is
strictly regulated by the specialized hematopoietic microen-
vironment, which includes stromal cells. Based on the gap
junction-like structures observed in the bone marrow, it was
hypothesized that gap junctions help to coordinate function-
al networks of stromal cells that support blood cell forma-
tion [19–22] and subsequent studies have supported this
idea as described below.
In vitro studies of cultured bone marrow or thymic
stromal cells revealed Cx43 as the principal gap junction
protein expressed by these primary cell types [23–25]. In
addition, Cx31 and Cx45 have been detected in some
stromal cell lines [26]. Moreover, functional studies have
demonstrated the transfer of dye or electrical current be-
tween stromal cells [23,25]. The consistent observations of
high levels of Cx43 expression in neonatal bone marrow
and low expression of this protein in adult bone marrow has
lead to the hypothesis that GJIC is required during periods
of active hematopoiesis, as observed in the growing neonate
[24,27]. Consistent with this idea is the finding that drug-induced elimination of committed hematopoietic cells led to
a dramatic increase in Cx43 expression in the bone marrow
that returned to normal when hematopoietic progenitors had
replenished the hematopoietic compartments [24]. Con-
versely, differentiation of stromal cells into adipocytes, a
cell type found in the yellow non-hematopoitic bone mar-
row, was associated with reduced Cx43 expression levels
and decreased GJIC [28]. Evidence that the expression level
of Cx43 is critical for normal hematopoiesis in vivo was
obtained recently using Cx43-deficient mice [29]. Indeed,
lack of Cx43 expression during embryogenesis compro-
mised the terminal development of primary B and T
lymphocytes. In addition, the authors observed similar
defects in heterozygous Cx43 (Cx43+/ ) embryos that
express reduced levels of Cx43. However, the hematopoietic
system was returned to normal at 4 weeks of age in the
Cx43+/ mice. Interestingly, the regeneration of lymphoid
and myeloid cells in Cx43+/ mice was severely impaired
after drug-induced elimination of hematopoietic cells, thus
providing further support to the hypothesis that GJIC is
mostly required during periods of active hematopoiesis.
Gap junctions between stromal and hematopoietic cells
have also been observed in the bone marrow in situ and long-
term cultures of bone marrow [21]. Subsequent dye transfer
studies demonstrated functional coupling between these cell
types. It is thus tempting to hypothesize that GJIC between
stromal cells and hematopoietic cells may allow for direct
transfer of stromal cell-derived signals into developing he-
matopoietic cells, thus regulating blood cell formation. How-
ever, the actual existence of such a pathway remains contro-
versial. It has been reported that chemical blockade of GJIC
between stromal and hematopoietic cells decreased blood cell
formation, an effect that was more pronounced in primitive
than in committed progenitors [30]. In contrast, other
researchers have been unable to observe dye transfer between
stromal and hematopoietic cells or to detect connexin expres-
sion in hematopoietic progenitors by reverse transcription-
polymerase chain reaction (RT-PCR) [23,26,29]. Taken to-
gether, it appears that gap junctions may play a role in
hematopoiesis, particularly during active periods when blood
cell formation is initiating or regenerating. However, the
question as to whether GJIC between stromal cells, between
hematopoietic cells or between both cell types is most critical
for active hematopoiesis remains to be answered.
2.2. Connexin expression in leukocytes
The presence of gap junctions between leukocytes
(homocellular contacts) as well as between leukocytes and
other cells (heterocellular contacts) have been extensively
reported (Table 1). Furthermore, increasing information is
becoming available on the connexin isoforms expressed in
the different leukocytes as well as on the regulation/induc-
tion of GJIC by pro-inflammatory mediators in these cells
(Table 2). Nevertheless, most of these reports result from in
vitro studies and remain to be proven in vivo.
Table 1
Gap junction formation by leukocytes
Leukocytes Interactors Species Conditions Evidences References
Neutrophils Neutrophils Human LPS or TNF-a, unidentified
EC derived factor(s)
Dye coupling [33]
Neutrophils Neutrophils Hamster Ischemia reperfusion injury EM [31]
Neutrophils EC line Human Untreated Dye coupling [34]
Neutrophils Epithelial cell line Human Untreated Dye coupling [34]
Neutrophils ECs Hamster Ischemia reperfusion injury EM [31]
Monocytes Monocytes Human LPS or TNF-a and INF-g Dye coupling [39]
Monocytes Monocytes Hamster Ischemia reperfusion injury EM [31]
Monocytes Neutrophils Hamster Ischemia reperfusion injury EM [31]
Macrophages Macrophages Murine Arranged in chains Electrical coupling [35]
Macrophages Macrophages Murine Peritonitis EM [37]
Macrophages Macrophages Canine GM-CFC EM [36]
Macrophages Neutrophils Trout Bacterial agents EM [32]
Macrophages Epithelial cell line Murine Peritonitis Dye coupling, EM [37]
Microglial cells Microglial cells Murine LPS and INF-g or TNF-a
and INF-g or unstimulated
Dye coupling [38]
Lymphocytes Lymphocytes Human PHA Electrical coupling [46]
Lymphocytes Lymphocytes Human PHA Electrical coupling, EM [48]
Lymphocytes Lymphocytes Bovine PHA Electrical coupling [44,45]
Lymphocytes Lymphocytes Rabbit PHA EM [49]
Lymphocytes EC Murine Lymphnode in situ EM [50]
Lymphocytes Epidermal Langerhans cells Murine Antigen activated EM [51,52]
Lymphocytes Dermal Langerhans cells Human Dermatitis in situ EM [60]
Lymphocytes ECs Human HTLV-1 + Dye coupling [80]
Lymphocytes ECs Human Dye coupling [53]
EC, endothelial cell; LPS, lipopolysaccharide; TNF-a, tumor necrosis factor-a; INF-g, interferon-g; GM-CFC, granulocyte-macrophage colony-forming cell;
PHA, phytohemagglutinin; HTLV-1+, human T-cell leukemia virus type 1+; IF, immunofluorescence; WB, Western blot; NB, Northern blot; RT-PCR, reverse
sorter; EM, electron microscopy.
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Gap junction-like structures were initially observed by
electron microscopy (EM) between hamster neutrophils as
well as between neutrophils and ECs [31] and then detected
between trout neutrophils and macrophages [32]. After initial
transcriptase-polymerase chain reaction; FACS, fluorescence-activated cellTable 2
Connexin expression in leukocytes
Leukocytes Connexins Species Conditions
Neutrophils Cx43 Human LPS or TNF-a
Human Untreated
Hamster LPS
Cx40 Human LPS or TNF-a
Human Untreated
Cx37 Human Untreated
Monocytes/ Cx43 Human Atherosclerotic ma
macrophages Human LPS and INFg or
Mouse J774 macrophage
Mouse LPS and INF-g
Hamster LPS
Murine Brain stab wounds
of microglias
Cx37 Human and mouse Early atheromas
Lymphocytes Cx43 Human Peripheral blood o
Mouse Lymph node-deriv
Cx40 Human Tonsil-derived-cell
Cx37 Human Peripheral blood
Mouse Lymph node deriv
IF, immunofluorescence; WB, Western blot; NB, Northern blot; RT-PCR, reverse
sorter; EM, electron microscopy; LPS, lipopolysaccharide; TNF-a, tumor necrosifailure to detect connexin mRNA or protein in peripheral
blood cells, early studies indicated that connexin expression
in neutrophils is inducible. The presence of Cx43 was
detected by immunofluorescent staining (IF), only after
stimulation with lipopolysaccharide (LPS), in hamster andEvidences References
IF, WB [33]
IF, WB [34]
IF, WB, EM [31]
IF, WB [33]
IF, WB [34]
IF, WB [34]
crophage foam cells NB [40]
TNF-a and INFg WB, NB [39]
cell line WB, NB [42]
IF, WB, EM [41]
IF, WB, EM [31]
or primary cultures WB, EM [38]
IF [43]
r tonsil-derived cell WB, RT-PCR, FACS [54]
ed cells IF [81,82]
s WB, RT-PCR, FACS [54]
IF [58]
ed cells IF [81,82]; Discrepancy
with [54]
transcriptase-polymerase chain reaction; FACS, fluorescence-activated cell
s factor-a; INF-g, interferon-g.
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expression of both Cx40 and Cx43, but not Cx32, in human
neutrophils after stimulation with LPS or TNF-a [33]. Al-
though these activated human neutrophils were able to form
homocellular gap junctions in vitro, they were not dye-
coupled unless treated with EC derived factor(s) [33]. More
recently, it was demonstrated that unstimulated human neu-
trophils express Cx37, Cx40 and Cx43 [34]. Protein expres-
sion at the cell surface was confirmed by Western blots that
revealed the presence of all three connexins in the membrane
fractions. Cx37 was mainly localized in the pseudopodia of
neutrophils whereas Cx40 and Cx43 showed a more granular
organization. Importantly, expression of these connexins
permitted GJIC between neutrophils and ECs in a rapid
bidirectional and adhesion-dependent manner, which was
decreased after treatment with TNF-a [34]. Taken together,
there is various support for homocellular and heterocellular
gap junctions in neutrophils. However, additional evidence at
the level of messenger RNA is needed to verify the connexin
isoform expressed under the different conditions.
2.2.2. Monocytes/macrophages
The establishment of intercellular communication be-
tween macrophages, based on electrical coupling of adher-
ent murine macrophages, was first reported by Levy et al.
[35]. Subsequently, gap junctions were morphologically
detected between progeny of canine macrophages by freeze
fracture EM [36]. Gap junction structures have since been
described by EM between murine macrophages and an
intestinal epithelial cell line [37]; between hamster mono-
cytes as well as monocytes and neutrophils [31]; and
between rainbow trout macrophages and neutrophils [32].
Further support for GJIC between monocytes/macrophages
and other cells has come from dye transfer assays. Dye
coupling was observed between murine peritoneal macro-
phages as well as between murine macrophages and intes-
tinal epithelial cells [37]. At brain stab wounds and in
primary culture of murine microglias, a low dye coupling
was observed. This coupling was dramatically increased
with the treatment of IFN-g and LPS or IFN-g and TNF-a
as well as inhibited by a gap junction blocker [38]. In
addition, freshly isolated human monocytes treated with
LPS or TNF-a and IFN-g were dye-coupled [39]. However,
these studies are in conflict with other reports that demon-
strate the lack of GJIC between monocytes/macrophages
and other cells. For example, the transfer of dye was not
observed in untreated human or mouse monocytes/macro-
phages [40,41], between human monocytes/macrophages
and ECs or between human monocytes/macrophages and
SMCs [39,40]. To date, the expression of two connexin
isoforms in monocytes/macrophages has been reported. The
presence of Cx43 was found in the mouse macrophage cell
line J774 [42], activated peritoneal macrophages from
hamsters and mice [31,41]; brain stab wound and primary
cultures of murine microglia [38]; and human monocytes/
macrophages stimulated with TNF-a and INF-g or LPS andINF-g [39]. Moreover, Cx43 mRNA was detected in mac-
rophage foam cells of human atherosclerotic carotid arteries
[40]. Interestingly, we observed Cx37 but not Cx43 in
macrophages of early atheromas [43]. The induced expres-
sion of other connexins in monocytes/macrophages has been
examined and neither Cx32 nor Cx40 were detected after
treatment with LPS or TNF-a and IFN-g [39,40]. Until
these discrepancies become resolved, it remains unclear
whether monocytes/macrophages communicate via GJIC.
2.2.3. Lymphocytes
The initial observations that lymphocytes can establish
intercellular communication were reported in the early
1970s. Two separate groups detected electrical coupling
between lymphocytes isolated from bovine lymph nodes
or human peripheral blood after stimulation with phytohae-
magglutinin (PHA) [44–47]. Subsequently, the ultrastruc-
tural detection of gap junctions between PHA stimulated
lymphocytes was observed [48,49]. This was followed by
ultrastructural reports of heterocellular gap junctions be-
tween lymphocytes and ECs or Langerhans cells [50–52].
Moreover, bidirectional transfer of cytoplasmic fluorescent
dyes between lymphocytes and the endothelium has been
reported [53]. Connexin distribution and GJIC has been
studied in human and mouse lymphocyte subpopulations.
Human peripheral blood-derived T, B and natural killer
(NK) lymphocytes express solely Cx43, whereas tonsil-
derived T and B lymphocytes express both Cx40 and
Cx43 [54]. It is worth mentioning that Cx26, Cx32, Cx37
and Cx45 were not detected in these cells by RT-PCR [54].
However, the expression of Cx37 protein in human periph-
eral blood lymphocytes was previously reported by another
group [55]. Both human and mouse lymphocytes display
functional GJIC, as assayed by dye transfer, which can be
reduced by pharmacological agents or synthetic peptides
known to block gap junctional communication. Interesting-
ly, lymphocytes increase connexin expression or translocate
connexins towards cell–cell interfaces upon activation with
either PHA or concanavalin A [56–58].3. A role for gap junction communication in the immune
response
Cell-to-cell interactions are of major importance for
expanding the competency of cells in the immune system
to control infections and maintain tolerance. Activation of
the adaptive immune response includes the interaction
between T cell antigen receptors and major histocompati-
bility complex (MHC) molecule–peptide complexes. This
nanometer scale gap between the T lymphocyte and the
antigen-presenting cell (APC) is referred to as the immuno-
logical synapse [59]. Specificity of these recognitions is
critical, as reactions to microbial peptides are required for
clearance of many infections and responses to self-derived
peptides on APCs can give rise to autoimmunity. Despite
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the extensive characterization of connexin in primary and
secondary lymphoid organs, knowledge on the potential role
of gap junctions in the immune system is limited. However,
as specific connexin blocking peptides have become more
accessible, research on this topic pushes forward quickly.
Gap junctions, composed of at least Cx43, between
antigen-presenting Langerhans cells and T lymphocytes
were observed both in vitro and in vivo [51,52,55,60]. Saez
et al. [58] demonstrated first that synthetic peptides homol-
ogous to the extracellular loop of Cx43 drastically reduced
proliferation of mitogen-activated T cells, indicating that
GJIC may play a role in the adaptive immune response.
Subsequently, Oviedo-Orta et al. [57] elegantly showed that
disruption of GJIC influenced fundamental aspects of lym-
phocyte function, including immunoglobulin (Ig) secretion
and cytokine production. Indeed, inhibition of GJIC by
synthetic peptides homologous to the first and second
extracellular loop of Cx43 markedly reduced secretion of
IgM, IgG and IgA in mixed cultures of activated purified
human B and T lymphocytes. In addition, they observed in
these cultures complex temporal inhibitory effects on cyto-
kine synthesis, especially on interleukin-10. Taken together,
these results open up towards the novel hypothesis that
connexins, and likely GJIC itself, may be an important
component of the molecular mechanism underlying lym-
phocyte activation and function in the immune response.
Clearly, further studies are needed to identify which mole-
cules are passing through gap junction channels between
APCs and T cells as well as T and B lymphocytes.
Considering the narrow space of the immunological syn-
apse, involvement of gap junction hemichannels as passage-
way for metabolites to the extracellular space and leading to
paracrine cell–cell signaling should also be considered [61].4. Gap junction communication in leukocyte recruitment
Three connexins, namely Cx37, Cx40 and Cx43, have
been detected in the vascular endothelium in situ. The precise
distribution of these connexins within the vessel wall is
known to be species and vessel specific [62]. Cultured human
umbilical vein endothelial cells (HUVECs) also express the
three vascular connexins and they mainly locate at cell–cell
contacts [63]. Interestingly, TNF-a altered the connexin
expression pattern in HUVECs and reduced GJIC between
these ECs [63]. This reduction in GJIC within the endothe-
lium might serve two important purposes. First, it might
protect the endothelium by restricting the spread of injurious
signals via EC gap junctions, thus limiting the area of
inflammation. Second, as more connexons from the ECs
become available for docking, they might form heterocellular
gap junctions with leukocytes to control leukocyte migration
across the endothelium. As discussed below, there are recent
indications of gap junctions between ECs and leukocytes and
that GJIC might play a role in leukocyte extravasation.Cell communication via gap junctions during transmigra-
tion was first described by Oviedi-Orta et al. [64]. In this
study, they demonstrated by using dye transfer experiments
that lymphocytes and ECs generate functional heterocellular
gap junction channels during extravasation in vitro. Interest-
ingly, blocking GJIC with pharmacological agents or con-
nexin mimetic peptides caused only a modest reduction in
transmigration of lymphocytes across an EC monolayer [61].
Neutrophils and HUVECs also form functional gap junction
channels in vitro, as demonstrated by dye transfer experi-
ments [34]. Moreover, this bidirectional coupling was re-
duced when HUVECs were stimulated with TNF-a but not
when stimulated with IFN-g or thrombin. Therefore, cou-
pling between neutrophils and HUVECs is selectively mod-
ulated during an inflammatory reaction, suggesting that this
process might be of physiological relevance. Importantly,
neutrophil transmigration was enhanced when GJIC was
inhibited, suggesting a negative regulatory role for this
coupling during the transmigration process. It was also shown
in this study that strongly adherent neutrophils were more
coupled than weakly adherent ones and that the adhesive
properties between connexons played no role in this strength-
ened cell adhesion process. This prompts a novel hypothesis
that the tight adhesion, mediated by integrins and their
ligands, between leukocytes and ECs might be modulated
by signaling through gap junctions (Fig. 1). Finally, human
monocytes were shown to form gap junctions with ECs in a
blood brain barrier (BBB) model during the process of
transmigration [39]. In addition, blockade of GJIC reduced
the number of monocytes that transmigrated, suggesting that
cell-to-cell signaling through gap junction channels might
even affect the efficiency of the transmigration process across
a tight endothelium. Transendothelial migration (TEM) of the
different leukocytes appears to be differentially regulated by
GJIC, such that inhibition of GJIC increased TEM of neu-
trophils but decreased TEM of monocytes and had modest
effects on lymphocyte TEM. Of major concern in the afore-
mentioned studies is the specificity of the GJIC blocking
reagents, pharmaceutical agents are plainly unspecific and the
specificity of the mimetic peptides remains to be proven.
Clearly, more work is required before definitive proof dem-
onstrates that gap junctions do play a role in leukocyte TEM.
Interestingly, regulation of leukocyte recruitment via GJIC
might occur at different points of the multi-step adhesion
cascade namely tight adhesion and diapedesis (Fig. 1). Based
on current data, we hypothesize that there may be a cross talk
between gap junctions (formed between leukocytes and ECs)
and the integrin–IgSF CAM adhesion complex (also formed
between leukocytes and ECs). This form of communication
might then modulate the tight adhesion between leukocytes
and ECs, controlling whether a leukocyte returns to the blood
flow (the case for weak adhesion) or continues to transmi-
grate into extravascular tissues (the case for firm adhesion).
Likewise, we suggest that there may be cross talks between
gap junctions (formed between leukocytes and ECs) with the
EC tight and adherens junctions. The signals transmitted
Fig. 1. The role of gap junctions in leukocyte recruitment to tissues. Sequential steps in leukocyte emigration, including tethering/rolling, activation, tight
adhesion, and diapedesis (via inter-endothelial junctions TJ, AJ, GJ and SA), are controlled by specific cell adhesion molecules (CAMs). (1) Tight adhesion
(TA), mediated by leukocyte integrins and endothelial IgSF CAMs (molecules depicted in dark purple), is triggered by signals such as chemokines. An
alternative means to regulate this step might occur via the signaling molecules that pass through GJs formed between the leukocyte and EC (red arrow). This
cross talk with the IgSF CAM–integrin complex may modulate the tightness of adhesion, consequently determining whether the leukocyte returns to the blood
stream or continues to transmigrate. (2) Diapedesis, the passage of leukocytes across inter-endothelial junctions, appears to be controlled by both TJ and AJ;
and recent reports suggest that GJ also participates in this process. The blockage of GJIC increases TEM of neutrophils but reduces TEM of monocytes/
macrophages and has a minor effect on lymphocyte TEM. In this model, it is hypothesized that GJIC between the leukocyte and EC cross talks with the EC TJ
and AJ, signaling them to ‘‘open up’’ for the leukocytes to pass through (red arrows). IgSF, immunoglobulin supergene family; ECs, endothelial cells; TJ, tight
junction; AJ, adherens junction; GJ, gap junctional channel; GJIC, gap junctional intercellular communication; SA, syndesmos/complexus adherens; TEM,
transendothelial migration.
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to pass through. As this line of research continues, one
challenge will be to identify the signals that are being
exchanged through gap junctions between leukocytes and
ECs during different physiological states. This will certainly
further our understanding of leukocyte migration during
immune surveillance and inflammatory reactions that can
cause diseases when improperly controlled.5. Multiple roles for gap junction communication in
atherosclerosis
Atherosclerosis is a progressive disease characterized in
part by the accumulation of lipids, leukocytes, and smooth
muscle cells (SMCs) in the intima of medium and large
arteries [65]. This disease is presently the leading cause of
illness and death in developed countries. The current view
believes that inflammation is a major contributor to athero-
genesis [66]. Moreover, evidence is growing that dysfunc-
tional GJIC plays a role in the development of atherosclero-
sis. Initially, Polacek et al. [40] reported the strong expression
of Cx43 mRNA by macrophage foam cells in human athero-
sclerotic carotid arteries. They extended this finding in a
rabbit model of atherosclerosis, demonstrating that the ex-
pression of Cx43 is upregulated in macrophage foam cells
and downregulated in medial SMCs [67]. In another study,Cx43 expression in intimal SMCs was shown to increase at
early stages of human coronary atherosclerosis and to de-
crease at later stages of the disease [68]. A genetic polymor-
phism in the human Cx37 gene was reported as a potential
prognostic marker for atherosclerotic plaque development
[69]. Furthermore, this Cx37 gene polymorphism was shown
to possibly play a role in the manifestation of coronary
atherosclerosis in Taiwan and Japan [70,71]. More recently,
we demonstrated that expression of the three vascular con-
nexins is altered in mouse and human atherosclerotic plaques
[43] and that the reduction of Cx43 expression inhibits the
formation of atherosclerotic lesions in low-density lipopro-
tein receptor-deficient (LDLR /) mice [72,73]. These stud-
ies have provided valuable clues as to how gap junction
communication might play a role in the initiation as well as
the progression of atherosclerotic plaque development.
5.1. The ‘‘initiation’’ and progression of an atherosclerotic
plaque
The many risk factors that are implicated in atherogen-
esis are linked by their common ability to promote inflam-
matory reactions and injury to the endothelium. As a
response to injury, the endothelium becomes dysfunctional
leading to its increased expression of various cell adhesion
molecules and secretion of chemoattractants to recruit
specific leukocytes [74]. Leukocyte recruitment in the early
Fig. 2. Altered connexin expression during atherosclerotic plaque development. (1) Normal artery. Cx37 and Cx40 are expressed in ECs; Cx43 is expressed in
mSMCs; connexins are not detected in circulating monocytes. (2) Dysfunctional ECs. As a response to injury, ECs become dysfunctional and recruit
leukocytes, mainly monocytes/macrophages but also T lymphocytes, into the intima. Note the induced expression of Cx37 in intimal monocytes/macrophages.
(3) Fatty streak. As leukocytes accumulate in the intima, monocytes mature into macrophages that take up lipid into their cytoplasm and become macrophage
foam cells. Note the continued expression of Cx37 in the intima macrophages. (4) Early atheroma. Some mSMCs migrate into the intima, where the release of
pro-inflammatory molecules by themselves and leukocytes induce iSMC proliferation. Lipids start to accumate in the extracellular space and in iSMCs. Note
the increased expression of Cx43 in iSMCs compared to mSMCs, however the expression of connexins in ECs and mSMCs has not changed at this stage. (5)
Advanced atheroma. A fibrous cap is formed by iSMCs and ECM that covers the lesion area. The central core of this lesion contains necrotic debris,
extracellular lipids including cholesterol crystals. Note the disappearance of Cx37 and Cx40 in the diseased ECs, and the induced expression of Cx43 in ECs
covering the shoulder regions of the lesion. In addition to Cx37, Cx43 is also detected in macrophage foam cells located in the shoulder regions. Another
notable change at this stage is the reduced Cx43 expression in the iSMCs and the induced Cx37 expression in mSMCs. EC, endothelial cell; iSMC, intimal
smooth muscle cell; mSMC, medial smooth muscle cell; Cx, connexin; ECM, extracellular matrix; core, lipid and/or necrotic core.
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However, T lymphocytes are also implicated in the early
development of the disease [76]. After adhering to the
dysfunctional endothelium, the monocyte transmigrates be-
tween intact ECs to penetrate into the arterial intima. In the
intima, monocytes proliferate and mature under the influ-
ence of cytokines, chemokines and growth factors secreted
by themselves and other atheroma-associated cells. Further-
more, the induced expression of scavenger receptors permit
macrophages to accumulate lipids within their cytoplasm
and eventually progress to the arterial foam cells, a hallmark
of the arterial lesion. These foam cells along with the T cells
constitute the fatty streak known as the earliest form of
atherosclerotic plaques.
Evidently, diapedesis of leukocytes is a prerequisite for
the formation of atherosclerotic plaques. Thus, accelerating
or decelerating monocyte/macrophage diapedesis might
speed up or slow down atherosclerosis. In fact, transmigra-
tion of monocytes/macrophages but not T lymphocytes is
significantly reduced by inhibiting GJIC [39,64]. Moreover,
reducing the expression of Cx43 in LDLR / mice de-
creased the number of macrophages and T cells in the
atheroma as well as the progression of atherosclerosis [72].
Taken together, it appears that GJIC is somehow modified in
atherosclerosis leading to the enhanced leukocyte recruit-
ment. A possible mechanism for this transformation may be
via altered connexin expression resulting in the improper
exchange of signaling molecules that cause miscommunica-
tion. In fact, such alterations in connexin expression in
leukocytes and the endothelium are known to occur during
the development of atherosclerosis [43] (Fig. 2). Knowing
that the properties of individual gap junction channels are
distinct, it seems likely that the Cx37/Cx40 to Cx43 switch in
the endothelium and the Cx37 to Cx37/Cx43 switch in
macrophage foam cells will drastically change the messages
exchanged between these cells. It is worth mentioning that
since monocytes/macrophages can form gap junctions with
adjacent monocytes/macrophages, and perhaps even with
neighboring T lymphocytes and SMCs, miscommunication
among these cells might play an additional role in plaque
formation. For instance, lipid uptake by mature macrophages
might rely on GJIC.
5.2. The stability and rupture of an atherosclerotic plaque
The continued inflammatory response and accumulation
of lipids work together with other events to promote
atherosclerotic plaque growth and eventually rupture [66].
During the growing phase, medial SMCs migrate to the top
of the intima where they multiply and produce components
of the extracellular matrix (ECM). The SMCs and matrix
molecules coalesce to form a strong fibrous cap that covers
the original atherosclerotic site. Although this adds to the
size of the plaque, it also seals the plaque off safely from the
blood and reduces the chance of rupture. As this cap
matures, some of the cells underneath die and lipids arereleased. Therefore, this region is referred to as the lipid or
necrotic core of the atherosclerotic lesion. Eventually, the
fibrous cap of a plaque might break open, triggering a blood
clot to develop over the rupture. Plaques that are most likely
to break possess a thinned cap, a large lipid pool and many
macrophages. This plaque phenotype is partially dependent
on the activities of macrophages. Macrophage foam cells
secrete pro-inflammatory cytokines that amplify the local
inflammatory response in the lesion as well as reactive
oxygen species that further induce macrophage proliferation
and lipid uptake. In addition, the activated macrophages
produce matrix metalloproteinases (MMPs) that can degrade
the ECM thus weakening the plaque’s fibrous cap.
In addition to the initiation phase, GJIC might play a
role in the progression of atherosclerotic plaques. For
example, reducing Cx43 expression in LDLR / mice
led to the development of atherosclerotic lesions that
exhibited thicker fibrous caps with more collagen and
SMCs, a phenotype associated with plaque stability [72].
Thus, it seems beneficial to reduce Cx43 mediated GJIC in
atherosclerosis. Clearly, it will be interesting to see how
changes in expression of other connexins might affect this
disease. More recently, Eugenin et al. [39] showed that the
increased GJIC in monocytes enhanced the release of
MMP-2,3 but not MMP-9 by these cells. This amplified
release of MMPs in atherosclerotic lesions could be dele-
terious since it might promote plaque rupture and induce
thrombosis. Although it remains to be proven, we envision
that hemichannels on the macrophages in the lesions may
also play a role in plaque development. For instance, the
hemichannels might become misregulated such that they
convert from their normally closed state to an open state
leading to intracellular leakage and macrophage death.
Taken together, altered GJIC may affect several processes
required to promote atherosclerosis.6. Perspectives and future directions
Are connexins in leukocytes forming gap junction (hemi-)
channels to ‘‘shuttle messages’’? There is substantial evi-
dence in support of leukocyte homocellular and heterocellu-
lar gap junction assembly that allows for intercellular
communication. On the contrary, it remains only speculative
that hemichannels serve as bidirectional gateways between
the intra- and extracellular space possibly leading to paracrine
cell–cell signalling under particular circumstances. In vitro
studies show that altered GJIC affects the migration and
development of leukocytes, thus influencing the recruitment
of leukocyte subtypes to sites of inflammation as well as the
activation state of the immune system. Importantly, these
observations are corroborated by recent in vivo studies on
atherosclerosis. The dysregulation of GJIC is also implicated
in other inflammatory diseases and reactions such as acute
pancreatitis [18], cystic fibrosis [77], ischemia–reperfusion
injury in liver [78] and heart [79], as well as wound repair in
C.W. Wong et al. / Cardiovascular Research 62 (2004) 357–367 365skin [17]. We are far from identifying all the signals that go
through gap junction (hemi-) channels andwe know even less
about when and how those molecules might cross talk with
other molecules in any given situation. Perhaps, the answers
to some of our key questions might not be so far away as we
bridge ‘the gap’ between inter-disciplinary sciences.Acknowledgements
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